Timothy Schmid sold $63k of JNJ
EVP, WW Chair, MedTech at JOHNSON & JOHNSON. 403 shares at an average of $156.15, traded Feb 18, 2025, filed Feb 18, 2025.
Score components
- +20RoleChair
- +8Trade size$63k at market
- 0Share of holdings soldSold 2.6% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000200406-25-000060, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2025 | MOption exercise Common Stock | +499 | $0.00 | $0 | 13,539 | Feb 18, 2025 |
| Feb 14, 2025 | FTax withholding Common Stock | -193 | $155.26 | $30k | 13,346 | Feb 18, 2025 |
| Feb 14, 2025 | MOption exercise Common Stock | +1,765 | $0.00 | $0 | 15,111 | Feb 18, 2025 |
| Feb 14, 2025 | FTax withholding Common Stock | -639 | $156.71 | $100k | 14,472 | Feb 18, 2025 |
| Feb 15, 2025 | MOption exercise Common Stock | +1,029 | $0.00 | $0 | 15,501 | Feb 18, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stock | -403 | $156.15 | $63k | 15,098 | Feb 18, 2025 |
| Feb 13, 2025 | MOption exercise Restricted Share Unitsderivative | -499 | $0.00 | $0 | 499 | Feb 18, 2025 |
| Feb 14, 2025 | MOption exercise Restricted Share Unitsderivative | -1,765 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 15, 2025 | MOption exercise Restricted Share Unitsderivative | -1,029 | $0.00 | $0 | 2,056 | Feb 18, 2025 |
Related signals
Other insiders at JOHNSON & JOHNSON and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | JNJsell JOHNSON & JOHNSON | Timothy Schmid EVP, WW Chair, MedTech | $9.2M 33,597 shares | -92% | |
| 38Weak | JOHNSON & JOHNSON | Robert J Decker VP Corporate Controller | $1.2M 6,999 shares | -25% | |
| 60Notable | JOHNSON & JOHNSON | Joseph J Wolk Exec VP, CFO | $2.0M 13,015 shares | -100% | |
| 34Weak | JNJbuy JOHNSON & JOHNSON | Mark A Weinberger director | $147k 1,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.